Live Chat

Los Contratos por diferencia («CFD») son instrumentos complejos que comportan un riesgo elevado de pérdidas rápidas debido al apalancamiento. El 74% de las cuentas de inversores particulares pierde dinero al operar CFD con este proveedor. Debe considerar si comprende el funcionamiento de los CFD y si puede permitirse asumir un riesgo elevado de perder su dinero.

Close

Opere Bristol Myers BMY

BristolMyers gráfico en tiempo real

Perspectivas

Weekly Search
Weekly
Daily
Fecha Cerrar Cambio Cambio del % Apertura Alto Bajo

Noticias

Información

Spread

0.33

Spread (%)

0.6312 %

Apalancamiento

1:5

Interés a un día (Compra)

-0.0597 %

Interés a un día (Venta)

-0.0292 %

Divisa

USD

Horarios de los mercados

Markets closed

Viernes

13:31 - 19:59

Lunes

13:31-19:59

Martes

13:31-19:59

Miércoles

13:31-19:59

Jueves

13:31-19:59

Estado de resultados

Apertura

---

Cierre anterior

---

Máximo/mínimo de 52 semanas

--- – ---

Capitalización de mercado

106397949952

Acciones en circulación

2027399936

Fecha de ganancias (próxima)

2001-08-07

Rentabilidad por div. 

2024-11-01

Fecha exdividendo

2024-10-04

Tasa de dividendo anual anticipado

2.4

Rendimiento de dividendo anual anticipado

0.0449

GPA

-3.25

Acciones en circulación

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Conoce más sobre este instrumento

Activo
Vender
Comprar
Cambio del %
Instrumentos relacionados

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

New Zealand rate cut likely, FOMC and RBA minutes out

Sábado, 5 Octubre 2024

Adelanto semanal: Publicación de las actas del FOMC, probabilidad de más bajadas de tipos en Nueva Zelanda

Markets eye Powell speech, nonfarm payrolls for clues on future cuts

Jueves, 26 Septiembre 2024

Adelanto semanal: Los mercados buscarán pistas de recortes de tasas en noviembre en los comentarios de Powell y las cifras de empleo

RBA seen holding rates while SNB may go big with 50bps cut

Jueves, 19 Septiembre 2024

Adelanto semanal: Los mercados esperan que el SNB haga un gran recorte y el RBA se mantenga

Treasury yields, dollar pull back after higher-than-expected CPI reading triggers rally

Jueves, 12 Septiembre 2024

Adelanto semanal: La Reserva Federal reducirá tasas, ¿pero en cuánto?

Live Chat